In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Envoy Therapeutics Inc.

Division of Takeda Pharmaceutical Co. Ltd.
www.envoytherapeutics.com

Latest From Envoy Therapeutics Inc.

Takeda's Latest Investment Reflects Long-Term Shift In R&D Strategy

The Japanese pharma's new San Diego site brings together scientists from multiple locations to identify and validate therapeutic candidates across multiple modalities to enhance Takeda's global internal and external programs.

Research and Development Strategies Human Capital

Schizophrenia Dominates Psychiatric Drug Deal-Making Since 2008

Of 34 deals in the psychiatric disorder space since 2008, none have been mergers and acquisitions, but two-thirds of such transactions have involved licensing of compounds before regulatory approval. The major deals in the space have been a multi-compound collaboration between Otsuka and Lundbeck and the failed tie-up between AstraZeneca and Targacept.

BioPharmaceutical North America

Deals Shaping The Medical Industry, December 2012

Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Deals Of The Week: Sun/Dusa; Pfizer/Alliance For Lupus Research; Merck/Regenstrief Institute

Preclinical protein platform play Envoy got taken out by Takeda last week for up to $140 million. That magical “up to” typically hides a multitude of sins, but here that may not be the case.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Bradley Margus, CEO
    Robert Middlebrook, CFO
    Stephen Hitchcock, PhD, SVP, Drug Discovery
  • Contact Info
  • Envoy Therapeutics Inc.
    Phone: (561) 210-7705
    555 Heritage Dr.
    Juniper, FL 33458
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register